Skip Navigation LinksHome   >   Research & Development   >   Research Partners and the OCT Laboratory

Research Partners and the OCT Laboratory

OCT works with leading academic institutions across the world to evaluate its drug candidates for therapeutic potential. Working both in-house and with academic partners, OCT’s screening assays and disease models allow the company to conduct comprehensive studies on cannabinoids and determine their effect on pathways associated with disease progression across a range of indications.

OCT is also developing a laboratory in the UK, which will house a number of screening platforms, including cancer, immunology, and pain. The platforms will contain disease models for a range of indications, especially in cancer indications.